Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-29 01:46:19 - browse：347

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Celebrate National Dole Whip Day for 3 days this week at Disney

hotspot

WSS

Parkland mass shooting to be reenacted for lawsuit

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

DOJ, FTC to increase scrutiny of all types of health care mergers

Pediatricians' group reaffirms support for gender

Plane’s emergency slide plummets from sky, hits Chicago home

entertainment

Wikipedia

focus

Medicare proposal to cover medical devices draws a mixed reaction

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

California Joshua trees severely burned in massive wildfire

Peter Hotez and the public health issue of online harassment

Slain Parkland victim's father speaks out following reenactment

Hollywood unions extend contract negotiations for actors

Does Medicare's free annual wellness visit do any good?

Moonlake's readout produced a cash windfall. Risks remain

How dance can help health care workers heal from trauma

entertainment

Stanford updates investigation of president’s past research

Why the Crimean Bridge is key to Russia's war in Ukraine

Why some people catch Covid but never get sick

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Researchers separate signal from noise in heart wearable data

focus

hotspot

explore

hotspot